Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,205.49 +33.34 (+0.41%) Bitcoin USD
61,623.57 +3,235.61 (+5.54%) CMC Crypto 200
1,325.37 +48.39 (+3.79%)
Summit Therapeutics Inc. (SMMT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 09:53AM EDT. Market open.
| Previous close | 4.0600 |
| Open | 4.0800 |
| Bid | 4.2200 x 100 |
| Ask | 4.2700 x 100 |
| Day's range | 4.0650 - 4.3300 |
| 52-week range | 1.5000 - 5.2200 |
| Volume | |
| Avg. volume | 2,224,230 |
| Market cap | 2.98B |
| Beta (5Y monthly) | -1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9900 |
| Earnings date | 01 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.50 |
Insider MonkeySummit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript
Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2024 Earnings Call Transcript May 1, 2024 Summit Therapeutics Inc. reports earnings inline with expectations. Reported EPS is $-0.06 EPS, expectations were $-0.06. SMMT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies […]
- GuruFocus.com
Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights ...
Explore key takeaways from Summit Therapeutics' Q1 2024 earnings, including robust financial positioning and pivotal clinical advancements.
- Thomson Reuters StreetEvents
Q1 2024 Summit Therapeutics Inc Earnings Call
Q1 2024 Summit Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.